RT Journal Article
SR Electronic
T1 Sensitive extraction-free SARS-CoV-2 RNA virus detection using a novel RNA preparation method
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.29.21250790
DO 10.1101/2021.01.29.21250790
A1 Guan, Bin
A1 Frank, Karen M.
A1 Maldonado, José O.
A1 Beach, Margaret
A1 Pelayo, Eileen
A1 Warner, Blake M.
A1 Hufnagel, Robert B.
YR 2021
UL http://medrxiv.org/content/early/2021/02/01/2021.01.29.21250790.abstract
AB Current conventional detection of SARS-CoV-2 involves collection of a patient sample with a nasopharyngeal swab, storage of the swab during transport in a viral transport medium, extraction of RNA, and quantitative reverse transcription PCR (RT-qPCR). We developed a simplified and novel preparation method using a Chelex resin that obviates RNA extraction during viral testing. Direct detection RT-qPCR and digital-droplet PCR was compared to the current conventional method with RNA extraction for simulated samples and patient specimens. The heat-treatment in the presence of Chelex markedly improved detection sensitivity as compared to heat alone, and lack of RNA extraction shortens the overall diagnostic workflow. Furthermore, the initial sample heating step inactivates SARS-CoV-2 infectivity, thus improving workflow safety. This fast RNA preparation and detection method is versatile for a variety of samples, safe for testing personnel, and suitable for standard clinical collection and testing on high throughput platforms.Competing Interest StatementNEI (B.G. and R.B.H.) filed an invention disclosure. NEI has protected the intellectual property around this technology which is available for licensing and co-development. Please contact neitechtransfer@nei.nih.gov for more information.Funding StatementIntramural Research Programs of the National Institutes of Health (Clinical Center, NEI, NIDCR)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Samples were collected from healthy volunteers and subjects who provided informed consent to National Institutes of Health (NIH) Institutional Review Board (IRB)-approved protocols (20-D-0094, NCT04348240; 20-CC-0128, NCT04424446) at the NIH Clinical Center.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMethodology paper, thus not applicable here.